Veerle M H Coupe
Overview
Explore the profile of Veerle M H Coupe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
1536
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Wifferen F, Greuter M, Coupe V
Gastroenterology
. 2025 Mar;
PMID: 40024552
No abstract available.
2.
3.
Boute T, van Eekelen R, Elferink M, Birgit 1st L, de Wilt J, Vink G, et al.
Cancer Med
. 2025 Feb;
14(5):e70667.
PMID: 40013322
Introduction: After colorectal cancer (CRC) treatment, patients undergo five-year follow-up involving carcinoembryonic antigen (CEA) tests, imaging, and colonoscopies. This retrospective cohort study explores adherence to the CRC follow-up guideline in...
4.
Kramer A, van Schaik L, van den Broek D, Meijer G, Gutierrez Ibarluzea I, Galnares Cordero L, et al.
Pharmacoeconomics
. 2025 Feb;
PMID: 39920559
Background: Cost-effectiveness analysis (CEA) of biomarkers is challenging due to the indirect impact on health outcomes and the lack of sufficient fit-for-purpose data. Hands-on guidance is lacking. Objective: We aimed...
5.
Carvalho B, de Klaver W, van Wifferen F, van Lanschot M, van Wetering A, van der Zander Q, et al.
Gastroenterology
. 2024 Sep;
168(1):121-135.e16.
PMID: 39218164
Background & Aims: Colonoscopy-based surveillance to prevent colorectal cancer (CRC) causes substantial burden for patients and health care. Stool tests may help to reduce surveillance colonoscopies by limiting colonoscopies to...
6.
Akwiwu E, Klausch T, Jodal H, Carvalho B, Loberg M, Kalager M, et al.
Am J Epidemiol
. 2024 Aug;
PMID: 39214647
To optimize colorectal cancer (CRC) surveillance, accurate information on the risk of developing CRC from premalignant lesions is essential. However, directly observing this risk is challenging since precursor lesions, i.e.,...
7.
van Wifferen F, Greuter M, van Leerdam M, Spanier M, Dekker E, Vasen H, et al.
Gastroenterology
. 2024 Aug;
168(1):136-149.
PMID: 39214503
Background & Aims: The authors assessed whether familial colorectal cancer (FCRC) surveillance in individuals without hereditary CRC can be optimized METHODS: The Adenoma and Serrated Pathway to Colorectal Cancer (ASCCA)-FCRC...
8.
Kramer A, Greuter M, Schraa S, Vink G, Phallen J, Velculescu V, et al.
Ther Adv Med Oncol
. 2024 Aug;
16:17588359241266164.
PMID: 39175989
Background: Current patient selection for adjuvant chemotherapy (ACT) after curative surgery for stage II colon cancer (CC) is suboptimal, causing overtreatment of high-risk patients and undertreatment of low-risk patients. Postoperative...
9.
Pilz da Cunha G, Coupe V, Zonderhuis B, Bonjer H, Erdmann J, Kazemier G, et al.
HPB (Oxford)
. 2024 Jun;
26(8):971-980.
PMID: 38853074
Background: Minimally invasive liver surgery (MILS) is increasingly performed via the robot-assisted approach but may be associated with increased costs. This study is a post-hoc comparison of healthcare cost expenditure...
10.
Boute T, Swartjes H, Greuter M, Elferink M, van Eekelen R, Vink G, et al.
Cancer Res Commun
. 2024 Feb;
4(2):607-616.
PMID: 38363145
Significance: Population-based data on recurrent colorectal cancer are rare, but crucial for counseling patients and their physicians. This large nationwide, population-based study provides an up-to-date overview of the epidemiology of...